2 unchanged sentences
The principal market for AbbVie's common stock is the New York Stock Exchange (Symbol:
−Removed: AbbVie's common stock is also listed on the Chicago Stock Exchange and traded on various regional and electronic exchanges.
−Removed: There were 56,544 stockholders of record of AbbVie common stock as of January 31, 2025.
+Added: AbbVie's common stock is also listed on the NYSE Texas and traded on various regional and electronic exchanges.
+Added: There were 58,040 stockholders of record of AbbVie common stock as of February 10, 2026.
Performance Graph
4 unchanged sentences
2025 Form 10-K |
−Removed: On October 30, 2024, AbbVie's board of directors declared an increase in the company’s quarterly dividend from $1.55 per share to $1.64 per share, payable on February 14, 2025, to stockholders of record as of January 15, 2025.
+Added: On October 31, 2025, AbbVie announced that its board of directors declared an increase in the company’s quarterly dividend from $1.64 per share to $1.73 per share, payable on February 17, 2026, to stockholders of record as of January 16, 2026.
The timing, declaration, amount of and payment of any dividends by AbbVie in the future is within the discretion of its board of directors and will depend upon many factors, including AbbVie's financial condition, earnings, capital requirements of its operating subsidiaries, covenants associated with certain of AbbVie's debt service obligations, legal requirements, regulatory constraints, industry practice, ability to access capital markets and other factors deemed relevant by its board of directors.
24 unchanged sentences
| 2025 Form 10-K
−Removed: 2024 Form 10-K |
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.